Image_6_Trends in Incidence and Mortality of Waldenström Macroglobulinemia: A Population-Based Study.TIF by Xuejiao Yin (5132441)

“…</p><p>Results: The incidence of WM showed an initial rapid increase from 1980 to 1993 {annual percentage change (APC), 14.1% [95% confidence interval (CI), 10 to 18.4%]}, whereas it began to stabilize from 1993 to 2016 [APC, 0.5% (95% CI, −0.3 to 1.3%)]. The WM IBM trend followed a similar pattern, with a decrease occurring around 1994. …”

The optimal number of personnel for good quality of chest compressions: A prospective randomized parallel manikin trial by Syunsuke Yamanaka (4710133)

“…</p><p>Methods</p><p>We conducted a randomized, manikin trial on healthcare providers. …”

Metabolic syndrome in pregnancy and risk for adverse pregnancy outcomes: A prospective cohort of nulliparous women by Jessica A. Grieger (6041222)

“…Women with MetS were at an increased risk for PE by a factor of 1.63 (95% CI 1.23 to 2.15) and for GDM by 3.71 (95% CI 2.42 to 5.67). …”

Genetic Polymorphisms in XRCC1, CD3EAP, PPP1R13L, XPB, XPC, and XPF and the Risk of Chronic Benzene Poisoning in a Chinese Occupational Population by Ping Xue (167911)

“…However, the T allele in PPP1R13L rs1005165 (P<0.05) and the GA allele in CD3EAP rs967591 (OR = 0.162; 95% CI: 0039~0.666; <i>P</i> = 0.037) decreased the risk of CBP in men. The haplotype analysis of XRCC1 indicated that XRCC1 rs25487^A, rs25489^G and rs1799782^T (OR = 15.469; 95% CI: 5.536–43.225; <i>P</i><0.001) were associated with a high risk of CBP.…”

A Dominated Coupling From The Past algorithm for the stochastic simulation of networks of biochemical reactions-4 by Martin Hemberg (51865)

“…The lines indicate a linear fit for the means and a quadratic fit for the variances. …”

Table 1_Denosumab in patients with osteogenesis imperfecta and a historical control study with alendronate.docx by Yazhao Mei (13041882)

“…This prospective cohort study evaluated the 12-month efficacy and safety of denosumab in OI patients, with a historical control study with alendronate.</p>Materials and methods<p>Eight pediatric patients (1 mg/kg every 3 months; ≤60 mg/dose) and ten adults (60 mg every 6 months) received denosumab. …”

Image 1_Denosumab in patients with osteogenesis imperfecta and a historical control study with alendronate.tif by Yazhao Mei (13041882)

“…This prospective cohort study evaluated the 12-month efficacy and safety of denosumab in OI patients, with a historical control study with alendronate.</p>Materials and methods<p>Eight pediatric patients (1 mg/kg every 3 months; ≤60 mg/dose) and ten adults (60 mg every 6 months) received denosumab. …”

Image 2_Denosumab in patients with osteogenesis imperfecta and a historical control study with alendronate.tif by Yazhao Mei (13041882)

“…This prospective cohort study evaluated the 12-month efficacy and safety of denosumab in OI patients, with a historical control study with alendronate.</p>Materials and methods<p>Eight pediatric patients (1 mg/kg every 3 months; ≤60 mg/dose) and ten adults (60 mg every 6 months) received denosumab. …”

Schematic description of integrating a small example metabolic network with gene expression data. by Xin Fang (134979)

“…Finally, in Step V, we constructed the new metabolic state by calculating the new average normalized flux for each reaction as the mean of its new minimum and maximum fluxes. …”

Incidence and survival of laryngeal cancer in Denmark: a nation-wide study from 1980 to 2014 by Arvin Nahavandipour (6415004)

“…Considering the anatomic location, we found that glottic cancer had a significantly better survival at five years compared to the other locations. …”

Voice-related quality of life: impact of a speech-language pathology intervention with teachers by Tânia Maestrelli Ribas (12824220)

“…Regarding the V-RQOL vocal self-assessment remained virtually unchanged, but there was a slight increase in the global and physical average scores and decrease in the social-emotional domain (not significant). …”

MVEC-EVs promoted OPC survival, proliferation, and motility in a dose-dependent manner. by Masashi Kurachi (106280)

“…(A) The proportion of pyknotic nuclei decreased at doses ≥ 50 μg/ml. …”

Supplementary Material for: Epidemiology of Transthyretin Familial Amyloid Polyneuropathy in Portugal: A Nationwide Study by Inês M. (5678270)

Map showing the intervention and control LGAs. by Chinwe C. Eze (8787503)

“…However, post-intervention, the adjusted mean SARI Stigma Score significantly decreased in the intervention group compared to the control group, with an adjusted mean difference of 37.72 (95% CI: 36.01–39.43, p < 0.000).…”

Consort diagram. by Chinwe C. Eze (8787503)

“…However, post-intervention, the adjusted mean SARI Stigma Score significantly decreased in the intervention group compared to the control group, with an adjusted mean difference of 37.72 (95% CI: 36.01–39.43, p < 0.000).…”

The impact of the COVID-19 pandemic on dental trauma attendance: a systematic review and meta-analysis by Débora e Silva CAMPOS (14524435)

“…Meta-analysis was performed in RevMan 5.4 software with Odds Ratios as a pooled measure of effect, with a 95% confidence interval, and using random-effects modeling. …”

Table_1_A Pilot Study on Serial Nerve Ultrasound in Miller Fisher Syndrome.DOCX by Hsueh-Wen Hsueh (9241082)

“…</p><p>Methods: All MFS patients (n = 5) and healthy controls (n = 18), underwent a standardized sonographic protocol that evaluated nerve sizes of facial, large arm and leg nerves, and spinal nerve roots. …”

Data Sheet 1_Case series: Effects of a ketogenic diet on cardiometabolic health in seven outpatients with bipolar disorder.pdf by Louis Schreel (22385035)

“…</p>Results<p>Beneficial cardiometabolic effects included a decrease in mean Lp(a) of 6.6 mg/dl (−21%), a reduction in mean triglyceride of 40.6 mg/dl (−30%), a reduction in mean apoB of 0.14 g/L (−10,5%) and an increase in mean HDL-C of 3 mg/dL (+5%), a reduction in mean hsCRP of 0.94 mg/L (−45%), a reduction in mean TNF-α of 1.31 pg/ml (−7%), a reduction in mean MDA-LDL of 36.77 U/L (−38%), a reduction in mean nitrotyrosine of 225 nmol/L (−28%), a mean weight reduction of 4 kg (−4,6%), a mean visceral fat reduction of 0.69% (−10%) and a mean fat mass reduction of 3.7 kg (−12%). …”

Image_1_Lauflumide (NLS-4) Is a New Potent Wake-Promoting Compound.TIF by Gianina Luca (5633018)

“…Spectral analysis of the NREM EEG after NLS-4 treatment indicated an increased power density in delta activity (0.75–3.5 Hz) and a decreased power in theta frequency range (6.25–7.25 Hz), while there was no differences after modafinil treatment. …”

Annual measurements of vegetation cover on line-point intercept transects from the three Conmod Pilot study locations at Jornada Basin LTER, 2008-2016 by Debra Peters (17483247)